newsfilter
← Latest News
PR Newswire·

Synaptogenix to Present at Sachs 5th Annual Neuroscience Innovation Forum

NEW YORK, March 22, 2022 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced today that Dr. Daniel Alko